Capital International, Inc./CA/
Position in ALNY — Alnylam Pharmaceuticals, Inc.
CIK 895213
Los Angeles, CA
Position in ALNY
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$7,727,741
-$725,987 QoQ
Shares Held
25,671
+0.5% QoQ
Ownership
0.019%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#210
of 780 holders
Holding Since
Mar 2022
18 quarters on record
Voting authority
Sole 94%
Shared 0%
None 6%
Common Shares in ALNY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Capital International, Inc./CA/ holds $249,590,047 across 7 Biotechnology names. ALNY ranks #5 (3.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ONC |
BeOne Medicines Ltd.
|
305,477 | $87,051,780 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
164,407 | $81,665,889 | |
| 3 | RPRX |
Royalty Pharma plc
|
1,074,948 | $60,272,334 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
13,154 | $8,202,045 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
This page
|
25,671 | $7,727,741 | |
| 6 | ASND |
Ascendis Pharma A/S
|
10,443 | $2,785,356 | |
| 7 | CRSP |
CRISPR Therapeutics AG
|
34,560 | $1,884,902 |
All Filings in ALNY
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,727,741 | 25,671 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $8,453,728 | 25,550 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $23,680,852 | 59,552 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $34,490,928 | 75,638 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $23,423,370 | 71,831 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $18,080,809 | 66,961 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $24,727,551 | 105,085 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $34,439,531 | 125,221 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $27,698,112 | 113,984 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $13,955,043 | 93,376 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $19,145,211 | 100,022 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $17,085,368 | 96,473 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $10,987,459 | 57,847 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $10,274,813 | 51,292 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $11,219,456 | 47,210 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $7,818,649 | 39,062 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $6,149,473 | 42,163 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $3,166,193 | 19,390 | Shares | Defined | 2022-05-19 | |
| No filing history on record for this holder in this stock. | ||||||